Filing Details
- Accession Number:
- 0001415889-24-007814
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-13 16:30:21
- Reporting Period:
- 2024-03-11
- Accepted Time:
- 2024-03-13 16:30:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1082554 | United Therapeutics Corp | UTHR | Pharmaceutical Preparations (2834) | 521984749 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1106578 | A Martine Rothblatt | C/O United Therapeutics Corporation 1000 Spring Street Silver Spring MD 20910 | Chairperson & Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-03-11 | 15,000 | $129.49 | 15,130 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-03-11 | 1,269 | $244.80 | 13,861 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-03-11 | 1,137 | $246.05 | 12,724 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-03-11 | 3,531 | $246.91 | 9,193 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-03-11 | 2,404 | $247.99 | 6,789 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-03-11 | 2,079 | $249.05 | 4,710 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-03-11 | 4,580 | $249.76 | 130 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-03-12 | 15,000 | $129.49 | 15,130 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-03-12 | 7,091 | $247.20 | 8,039 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-03-12 | 4,443 | $248.09 | 3,596 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-03-12 | 2,694 | $249.15 | 902 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-03-12 | 772 | $249.82 | 130 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options | Disposition | 2024-03-11 | 15,000 | $0.00 | 15,000 | $129.49 |
| Common Stock | Stock Options | Disposition | 2024-03-12 | 15,000 | $0.00 | 15,000 | $129.49 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 641,654 | 2014-12-31 | 2024-12-31 | No | 4 | M | Direct |
| 626,654 | 2014-12-31 | 2024-12-31 | No | 4 | M | Direct |
Footnotes
- This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.
- This transaction was executed in multiple trades at prices ranging from $244.365 to $245.22. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $245.385 to $246.335. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $246.425 to $247.41. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $247.46 to $248.43. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $248.46 to $249.44. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $249.465 to $250.14. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $246.66 to $247.65. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $247.69 to $248.62. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $248.69 to $249.675. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $249.72 to $250.36. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
